tyyppi : |
Lehti |
Internet-yhteys : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4750 |
|
tutkimus Joukkueet : |
Sydney - National Institute of Complementary Medicine, Western Sydney University |
Tekijät : |
Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J. |
Otsikko : |
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets. |
Numero : |
Int J Pharm Compound ;24,1:77-82 2020 |
|
Todisteiden määrä : |
|
fyysinen vakaus : |
|
kemiallinen stabiilisuus : |
|
Muut menetelmät : |
|
commentairesvaleur : |
|
Luettelo yhdisteistä
Metronidazole
|
|
|
|
|
3000 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|